JP2010523104A - ガン細胞検出方法ならびにガン疾患の診断およびガン疾患の処置のモニタリングのためのその使用 - Google Patents

ガン細胞検出方法ならびにガン疾患の診断およびガン疾患の処置のモニタリングのためのその使用 Download PDF

Info

Publication number
JP2010523104A
JP2010523104A JP2010501666A JP2010501666A JP2010523104A JP 2010523104 A JP2010523104 A JP 2010523104A JP 2010501666 A JP2010501666 A JP 2010501666A JP 2010501666 A JP2010501666 A JP 2010501666A JP 2010523104 A JP2010523104 A JP 2010523104A
Authority
JP
Japan
Prior art keywords
cell
cells
cancer
substrate
electrical signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010501666A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523104A5 (https=
Inventor
ジュディス リシュポン，
レイチェラ ポポヴツァー，
ヨシ シャチャム−ディアマンド，
トヴァ ヌーフェルド，
セフィ ヴァーニック，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd filed Critical Ramot at Tel Aviv University Ltd
Publication of JP2010523104A publication Critical patent/JP2010523104A/ja
Publication of JP2010523104A5 publication Critical patent/JP2010523104A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrochemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2010501666A 2007-04-02 2008-04-02 ガン細胞検出方法ならびにガン疾患の診断およびガン疾患の処置のモニタリングのためのその使用 Pending JP2010523104A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90744107P 2007-04-02 2007-04-02
PCT/IL2008/000457 WO2008120216A1 (en) 2007-04-02 2008-04-02 Methods of detecting cancer cells and use of same for diagnosing and monitoring treatment of the disease

Publications (2)

Publication Number Publication Date
JP2010523104A true JP2010523104A (ja) 2010-07-15
JP2010523104A5 JP2010523104A5 (https=) 2011-05-06

Family

ID=39530621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010501666A Pending JP2010523104A (ja) 2007-04-02 2008-04-02 ガン細胞検出方法ならびにガン疾患の診断およびガン疾患の処置のモニタリングのためのその使用

Country Status (6)

Country Link
US (2) US8268577B2 (https=)
EP (1) EP2142661B1 (https=)
JP (1) JP2010523104A (https=)
KR (1) KR20100015774A (https=)
CN (1) CN101702920B (https=)
WO (1) WO2008120216A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015144904A (ja) * 2015-04-20 2015-08-13 佐藤　洋 位置制御システム

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010523104A (ja) 2007-04-02 2010-07-15 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド ガン細胞検出方法ならびにガン疾患の診断およびガン疾患の処置のモニタリングのためのその使用
US9707403B2 (en) 2007-12-12 2017-07-18 Neuro Code Tech Holdings, Llc Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics
US8656930B2 (en) 2008-01-10 2014-02-25 Neuro-Code Tech Holdings, LLC Method and system for processing cancer cell electrical signals for medical therapy
KR20110009162A (ko) 2008-04-17 2011-01-27 더 뉴로-시그널링 파운데이션 의약적 치료를 위해 악성 종양 세포에서 세포자멸사를 유도해내는 시스템 및 방법
WO2013011513A1 (en) * 2011-07-21 2013-01-24 Ramot at Tel- Aviv University Ltd. Methods of determinig enzyme activity in preserved cell samples
RU2489710C1 (ru) * 2012-02-20 2013-08-10 Владимир Вадимович Мошкин Способ коммутационной хроноамперометрии
EP2855697A1 (en) * 2012-05-31 2015-04-08 Ramot at Tel-Aviv University Ltd. Methods and system for detecting melanoma
KR20150074487A (ko) 2013-12-24 2015-07-02 삼성전자주식회사 식각 부산물 검출 방법 및 이를 이용한 자기 저항 메모리 장치의 제조 방법
US11154238B2 (en) 2015-08-07 2021-10-26 Electroceuticals, Llc Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals
US12472480B2 (en) * 2018-09-12 2025-11-18 Ohio State Innovation Foundation Chemical actuators
CN113720893B (zh) * 2021-09-01 2024-08-16 致慧医疗科技(上海)有限公司 一种基于癌细胞表面电荷强度的评估肿瘤恶性程度的方法
CN115224272A (zh) * 2022-06-09 2022-10-21 广东马车动力科技有限公司 一种正极浆料、正极极片及锂离子电池

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015595A1 (en) * 1990-04-03 1991-10-17 Oncotherapeutics An electronic technique of identifying an effective drug for treating a cancer patient

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US6682648B1 (en) * 1997-08-12 2004-01-27 University Of Southern California Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
CN1312480C (zh) * 2004-09-24 2007-04-25 南京大学 肿瘤细胞表面抗原的原位电化学免疫测定方法
US20060205090A1 (en) * 2005-03-14 2006-09-14 Newton Michael W Water-soluble conjugates for electrochemical detection
JP2010523104A (ja) 2007-04-02 2010-07-15 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド ガン細胞検出方法ならびにガン疾患の診断およびガン疾患の処置のモニタリングのためのその使用
KR101281761B1 (ko) * 2009-03-27 2013-07-26 서강대학교산학협력단 전기검출기반 줄기세포 분화 측정용 센서

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015595A1 (en) * 1990-04-03 1991-10-17 Oncotherapeutics An electronic technique of identifying an effective drug for treating a cancer patient

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6013013160; Ａｎａｌ．　Ｃｈｅｍ． Ｖｏｌ．７８, 2006, ｐｐ．７６２５-７６３１ *
JPN6013013162; Ｇａｓｔｒｏｅｎｔｅｒｏｌｏｇｙ Ｖｏｌ．９８，, 199005, ｐｐ．１１９９-１２０７ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015144904A (ja) * 2015-04-20 2015-08-13 佐藤　洋 位置制御システム

Also Published As

Publication number Publication date
CN101702920B (zh) 2013-03-13
EP2142661A1 (en) 2010-01-13
KR20100015774A (ko) 2010-02-12
US8530179B2 (en) 2013-09-10
CN101702920A (zh) 2010-05-05
US8268577B2 (en) 2012-09-18
EP2142661B1 (en) 2012-08-29
WO2008120216A1 (en) 2008-10-09
US20090232740A1 (en) 2009-09-17
US20120288877A1 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
JP2010523104A (ja) ガン細胞検出方法ならびにガン疾患の診断およびガン疾患の処置のモニタリングのためのその使用
JP6309516B2 (ja) 生体分子の相互作用を調節するために電極表面近傍でｐＨ／イオン濃度勾配を発生させる方法
Abdolahad et al. A vertically aligned carbon nanotube-based impedance sensing biosensor for rapid and high sensitive detection of cancer cells
Ceriotti et al. Assessment of cytotoxicity by impedance spectroscopy
Hekmatara et al. D2O-probed Raman microspectroscopy distinguishes the metabolic dynamics of macromolecules in organellar anticancer drug response
Sypabekova et al. An aptasensor for the detection of Mycobacterium tuberculosis secreted immunogenic protein MPT64 in clinical samples towards tuberculosis detection
Raucci et al. based screen-printed electrode to detect miRNA-652 associated to triple-negative breast cancer
Xing et al. A dual-channel intelligent point-of-care testing system for soluble programmed death-1 and programmed death-ligand 1 detection based on folding paper-based immunosensors
US20020127604A1 (en) Method to measure the activation state of signaling pathways in cells
Raucci et al. Electrochemical detection of miRNA using commercial and hand‐made screen‐printed electrodes: liquid biopsy for cancer management as case of study
KR20130061128A (ko) 항암 약물 후보물질 평가를 위한 시스템 및 방법
Gu et al. Cellular electrical impedance spectroscopy: an emerging technology of microscale biosensors
Wilson et al. Monitoring proteins and protein networks using reverse phase protein arrays
Primpray et al. A label-free electrochemical biosensor for detection of miRNA-34a breast cancer marker using disposable gold nanoparticles modified screen-printed reduced graphene oxide-molybdenum disulfide composited electrodes
US10246734B2 (en) System and method for detecting alpha-methylacyl-CoA racemase (AMACR) and prostate cancer
Mossberg et al. A direct electrochemical detection method of melanoma based on melanoma biomarker
Zhang et al. Imaging single bacterial cells with electro-optical impedance microscopy
US20150185218A1 (en) Methods and system for detecting melanoma
Ponti et al. Comparison of impedance-based sensors for cell adhesion monitoring and in vitro methods for detecting cytotoxicity induced by chemicals
US20140256581A1 (en) Viral nanoarrys and sensors comprising the same
WO2002042732A2 (en) A method to measure the activation state of signaling pathways in cells
WO2013011513A1 (en) Methods of determinig enzyme activity in preserved cell samples
Aslan et al. Electrochemical and Spectrophotometric Investigation of DNA Interactions with TURKOVAC and Pfizer-BioNTech Vaccines: Implications for Biosensor Sensitivity
Butler et al. Agar-integrated three-dimensional microelectrodes for on-chip impedimetric monitoring of bacterial viability
Oladimeji et al. Application of biosensors in environmental pollution and medicine

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110308

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130319

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130612

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130619

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20131224